Phase 1 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with any type of solid cancer that has spread (metastatic), confirmed through a tissue or cell sample, with at least one tumour in the abdomen or pelvis that has not been treated with radiation, and that can be measured using standard imaging criteria.
- People who are over 18 years of age.
- People who are generally well enough to carry out light activity and care for themselves (a doctor will assess this using a standard scale).
- People whose doctors estimate they are likely to live for at least 12 months.
- People whose blood test results show that their liver, kidneys, and blood cell counts are within acceptable ranges (the trial site can confirm what specific values are required).
- People who are able to understand the study and are willing to sign a consent form agreeing to take part.
Who may not be able to join:
- People who still have significant side effects from a previous cancer treatment at the time of joining (except for mild nerve-related symptoms, hair loss, or fatigue).
- People who are currently taking part in another clinical trial involving an experimental treatment.
- People who have cancer that has spread throughout the lining of the abdominal cavity, visible on scans.
- People who have active tumours visible on scans in parts of the body outside the abdomen or pelvis.
- People who have six or more active sites of cancer spread in the body.
- People whose target tumour has previously been treated with radiation therapy.
- People who have serious uncontrolled health conditions, such as an active infection, uncontrolled heart failure, unstable chest pain, irregular heart rhythm, or a mental health or personal situation that would make it difficult to follow the trial requirements.
- People who have any condition that their treating doctor determines would make it unsafe to receive the type of radiation treatment used in this trial (confirm with trial site).
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joshua Meyer, MD, Fox Chase Cancer Center
Phone: 12152141439
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess the ability of adaptive SBRT to deliver increased doses of radiation safely to patients with challenging anatomical locations of metastatic disease without causing unacceptable toxicity.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.